Aspirin may halt cancer spread
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Aspirin, the most versatile drug in the pharmacy, which is already known to prevent cancer, may also be an effective treatment for halting the disease once it has started.
An analysis of five large trials of people who took a daily low dose aspirin showed that among those who developed cancer it reduced its spread to distant organs by 40 to 50 per cent.
The spread of cancer, or "metastasis", is what most commonly kills patients after the disease has been initially diagnosed and treated.
The study is one of three published in The Lancet and Lancet Oncology which shows that taking aspirin for as little as two or three years can have a beneficial effect against cancer.
Study leader Professor Peter Rothwell of the University of Oxford said: "It seems likely aspirin will be of benefit when started after cancer is diagnosed."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments